Publication Cover
Canadian Journal of Respiratory, Critical Care, and Sleep Medicine
Revue canadienne des soins respiratoires et critiques et de la médecine du sommeil
Volume 3, 2019 - Issue 1
75
Views
1
CrossRef citations to date
0
Altmetric
Clinical Pathological Conference

Adalimumab drug induced pulmonary infiltrates and eosinophilia

&
Pages 5-8 | Received 15 May 2018, Accepted 05 Jun 2018, Published online: 04 Oct 2018

References

  • Allen, James. Drug-induced eosinophilic lung disease. Clin Chest Med. 2004; 25(1): 77–88.
  • Allen, James. Drug-induced eosinophilic lung disease. Clin Chest Med. 2004; 25(1): 77–88.
  • Allen, James. Drug-induced eosinophilic lung disease. Clin Chest Med. 2004; 25(1): 77–88.
  • Alas R., Williams M.T., Yamin G., & Rofoogaran M. Chronic cough and an atypical pattern of peripheral pulmonary opacities: A case report secondary to suspected drug onset. J Asthma. Published online April 2017.
  • Perez-Alvarez R., M. Perez-de-Lis M., Diaz-Lagares C.et al., Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases. Semin Arthritis Rheum. 2011;41(2):256–264.
  • Bartal C, Sagy I, Barski L. Drug-induced eosinophilic pneumonia: A review of 196 case reports. Dalar L, ed. Medicine. 2018;97(4):9688.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.